Estrogen receptors alpha (ERalpha) and beta (ERbeta): subtype-selective ligands and clinical potential.
Article Details
- CitationCopy to clipboard
Paterni I, Granchi C, Katzenellenbogen JA, Minutolo F
Estrogen receptors alpha (ERalpha) and beta (ERbeta): subtype-selective ligands and clinical potential.
Steroids. 2014 Nov;90:13-29. doi: 10.1016/j.steroids.2014.06.012. Epub 2014 Jun 24.
- PubMed ID
- 24971815 [ View in PubMed]
- Abstract
Estrogen receptors alpha (ERalpha) and beta (ERbeta) are nuclear transcription factors that are involved in the regulation of many complex physiological processes in humans. Modulation of these receptors by prospective therapeutic agents is currently being considered for prevention and treatment of a wide variety of pathological conditions, such as, cancer, metabolic and cardiovascular diseases, neurodegeneration, inflammation, and osteoporosis. This review provides an overview and update of compounds that have been recently reported as modulators of ERs, with a particular focus on their potential clinical applications.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Estradiol Estrogen receptor alpha Protein Humans YesAgonistDetails Estradiol Estrogen receptor beta Protein Humans YesAgonistDetails